Thyroid and Metabolic Diseases Unit (UETeM)
The UETeM is a multidisciplinary group dedicated to the study of rare lipodystrophies, progeroid syndromes, and severe insulin resistance syndromes. Founded in 2003 by Professors Lado-Abeal and Araújo-Vilar, its focus lies on both the clinical and molecular aspects of these disorders, which belong to the group of ultra-rare diseases. The team includes clinical endocrinologists, biochemists, pharmacists, and biotechnologists.
Areas of interest:
- Etiopathogenesis of genetic lipodystrophies
- Neurodegeneration
- Aging mechanisms
- New genes discovery
- New treatments of lipodystrophies, progerias and insulin resistance syndromes
Research Lines
- Line 1: Pathogenic mechanisms of neurodegeneration of seipinopathies
- Line 2: Mechanisms of adipose tissue dysfunction in lipodystrophy syndromes
- Line 3: New clinical diagnostic tools in lipodystrophy syndromes
- Line 4: Use of IA for the diagnosis of lipodystrophy syndromes
- Line 5: Role of non coding RNAs in the pathogenesis of lipodystrophy syndromes
- Line 6: New therapeutic approaches in severe insulin resistance syndromes
- Line 7: Murine models of generalized lipodystrophy
Selected publications
Epidemiological and clinical data from the European Lipodystrophy Registry
Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy.
A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
Effect of β-Estradiol on Adipogenesis in a 3T3-L1 Cell Model of Prelamin A Accumulation.
Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study
Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain
Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy.
Does Seipin Play a Role in Oxidative Stress Protection and Peroxisome Biogenesis? New Insights from Human Brain Autopsies
Diagnosis and treatment of lipodystrophy: a step-by-step approach
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience
Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy
